Erasca, Inc. Income Taxes Paid
Erasca, Inc. (ERAS) reported Income Taxes Paid of $72.00 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2021-08-26
- 2021-06-30: Income Taxes Paid, Net 6 month $72.00K.
- 2020-06-30: Income Taxes Paid, Net 6 month $51.00K.
| Period end | Income Taxes Paid, Net 6 month |
|---|---|
| 2021-06-30 | $72.00K 10-Q · filed 2021-08-26 |
| 2020-06-30 | $51.00K 10-Q · filed 2021-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |